TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
121.81
-0.55 (-0.45%)
At close: May 15, 2025, 4:00 PM
121.10
-0.71 (-0.58%)
After-hours: May 15, 2025, 7:31 PM EDT
TransMedics Group Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for TransMedics Group stock ranges from a low of $75 to a high of $178. The average analyst price target of $122.89 forecasts a 0.89% increase in the stock price over the next year.
Price Target: $122.89 (+0.89%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 4 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $125 → $130 | Buy | Maintains | $125 → $130 | +6.72% | May 9, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $105 → $125 | Buy | Reiterates | $105 → $125 | +2.62% | May 9, 2025 |
| Piper Sandler | Piper Sandler | Buy Reiterates $90 → $105 | Buy | Reiterates | $90 → $105 | -13.80% | Apr 29, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 23, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 26, 2025 |
Financial Forecast
Revenue This Year
553.38M
from 441.54M
Increased by 25.33%
Revenue Next Year
666.99M
from 553.38M
Increased by 20.53%
EPS This Year
1.49
from 1.01
Increased by 47.95%
EPS Next Year
2.29
from 1.49
Increased by 53.50%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 583.1M | 720.8M | 858.0M | ||
| Avg | 553.4M | 667.0M | 776.5M | ||
| Low | 526.1M | 612.5M | 693.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 32.1% | 30.3% | 28.6% | ||
| Avg | 25.3% | 20.5% | 16.4% | ||
| Low | 19.2% | 10.7% | 4.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.89 | 3.14 | 4.20 |
| Avg | 1.49 | 2.29 | 3.02 |
| Low | 1.23 | 1.53 | 2.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 87.1% | 110.1% | 83.1% |
| Avg | 48.0% | 53.5% | 31.7% |
| Low | 22.3% | 2.3% | 3.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.